Starodubtseva I.A., Lesina V.S., Kostina N.E., Venderevskaya K.V.
Bronchial asthma and cardiovascular comorbidity: interconnections and approaches to therapy
|
№5 / 2022
|
Polyakova O.A., Ostroumova O.D. , Arablinsky A.V.
Drug safety and polymorbidity as important components of rational pharmacotherapy in cardiology
|
№4 / 2022
|
Izmozherova N.V., Popov A.A., Ryabinina A.V., Vikhareva А.A., Safianik E.A., Spevak A.V.
Analysis of the BsmI (rs1544410) polymorphism of the vitamin D receptor gene and the clinical effect of 25(OH)D level correction in a population of late postmenopausal women in Yekaterinburg
|
№4 / 2022
|
Alekseeva L.I., Lila А.M., Sharapova Е.P., Taskina Е.А., Kashevarova N.G., Strebkova Е.А., Mazurov V.I., Zonova Е.V., Otteva E.N., Yakupova S.P., Vinogradova I.B.
Multicenter prospective study of the efficacy and safety of the combined use of glycosaminoglycan-peptide complex and diacerein in patients with knee osteoarthritis
|
№2 / 2022
|
Zhugrova E.S., Mazurov V.I.
Osteoporosis and comorbidity
|
№10 / 2021
|
Zhugrova E.S., Mazurov V.I.
Modern principles of osteoporosis therapy
|
№10 / 2021
|
Gaydukova I.Z., Bashkinov A.R., Inamova O.V.
Topical non-steroidal antiinflammatory medicines in osteoarthritis treatment in patients with concomitant pathology
|
№10 / 2021
|
Shuginova T.N., Meldo A.A., Shaporova N.L., Moiseenko F.V., Klikunova K.A.
Pulmonary function test for chronic obstructive pulmonary disease patients with non-small cell lung cancer
|
№8 / 2021
|
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
|
№7 / 2021
|
Rukavishnikov G.V., Neznanov N.G., Martynov A.I., Mazo G.E.
Treatment of depression in patients with comorbid somatic diseases
|
№3 / 2020
|
Antropova O.N., Osipova I.V., Markina I.L., Vladimirova V.S., Rusakova A.A.
Clinical significance of non-cardial comboridity in patients with chronic heart failure
|
№3 / 2020
|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|